🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
1.330
-0.120 (-8.28%)
At close: Nov 19, 2026, 4:00 PM EST
1.320
-0.010 (-0.75%)
After-hours: Nov 19, 2026, 7:55 PM EST

CervoMed Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.014.019.747.14--
Revenue Growth
-99.86%-58.86%36.29%---
Cost of Revenue
21.8121.8218.88.441.34-
Gross Profit
-21.8-17.81-9.06-1.29-1.34-
Selling, General & Admin
10.2710.489.176.522.142.62
Research & Development
-2.85----2.42
Operating Expenses
7.4210.489.176.522.145.04
Operating Income
-29.23-28.29-18.23-7.81-3.48-5.04
Interest Expense
-----0-0
Interest & Investment Income
0.71.341.940.220.060.02
Other Non Operating Income (Expenses)
0-0.01-05.42-2.390.74
EBT Excluding Unusual Items
-28.52-26.97-16.29-2.17-5.8-4.28
Other Unusual Items
-----0.15
Pretax Income
-28.52-26.97-16.29-2.17-5.8-4.14
Net Income
-28.52-26.97-16.29-2.17-5.8-4.14
Net Income to Common
-28.52-26.97-16.29-2.17-5.8-4.14
Net Income Growth
------
Shares Outstanding (Basic)
1198315
Shares Outstanding (Diluted)
1198315
Shares Change
23.36%12.00%203.34%413.65%-88.49%-
EPS (Basic)
-2.60-2.98-2.02-0.82-11.20-0.92
EPS (Diluted)
-2.60-2.98-2.02-0.82-11.20-0.92
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---93.04%-18.11%--
Operating Margin
-334924.87%-706.22%-187.18%-109.35%--
Profit Margin
-326822.54%-673.06%-167.29%-30.40%--
EBIT
-29.23-28.29-18.23-7.81-3.48-5.04
EBIT Margin
---187.18%-109.35%--
SEC Filings: 10-K · 10-Q